Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.

A research partnership has revealed a new pathway to understanding the progression of pancreatic cancer.

Genetic testing for hereditary conditions such as breast cancer can have implications for the whole family. Learn how genetic testing helped Cathleen Argyle and her family to uncover a rare mutation and how the Rogel Cancer Center provided advice and guidance throughout the process.

GOT2 causes metabolic changes that pancreas tumors overcome.

A study suggests substances touted to improve athletic performance can activate a receptor that accelerates the progression of pre-cancerous lesions to pancreatic cancer in mice.

Often found in beauty products and wellness supplements, hyaluronic acid attracts and retains water well. It’s also a major player in the physiology of pancreatic tumors.

Cell culture study maps mechanisms underlying a new potential strategy for killing pancreatic cancer cells through a type of cell death known as ferroptosis.

Robin Schroeder was determined to continue her active lifestyle, even after she underwent a Whipple, a taxing operation with a difficult recovery period.

ApoE has known roles in cardiovascular disease and Alzheimer’s, but was not previously implicated in pancreatic cancer.

What do you do when you’re experiencing unexplained abdominal pain, weight loss and chronic fatigue and your doctor can’t tell you why? That’s what Michael Skaggs asked himself when scan after scan, test after test, and doctor after doctor were unable to help him.

Unexplained abdominal symptoms sidelined an otherwise healthy, active life. After countless failed attempts to find the cause, a chance introduction opened the door to answers and recovery.

The analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.

Rather than attacking cancer cells directly, new cell-model research probes weaknesses in pancreatic cancer’s interactions with other cells to obtain nutrients needed for tumor growth.

The protein Argonaute 2 was found to be critical to the progression from benign lesions into pancreatic cancer, suggesting a therapeutic opportunity.